Lecrolyn

Sodium cromoglicate, the active ingredient in Lecrolyn, is a mast cell stabilizer presented as an ocular solution for ocular use. It is indicated for the treatment of allergic conjunctivitis and helps reduce eye irritation in affected individuals.

GNH USA supplies Lecrolyn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for regulated prescription products. Clients benefit from comprehensive regulatory support and timely delivery across multiple regions.

Lecrolyn, a mast cell stabilizer, is used to manage ocular allergic conditions by preventing mediator release.

- Allergic conjunctivitis: reduces itching, redness and tearing associated with allergic eye inflammation. - Seasonal allergic conjunctivitis: provides relief during pollen seasons by stabilizing ocular mast cells. - Allergic eye irritation: alleviates discomfort caused by environmental allergens in the eye.

Lecrolyn is generally well tolerated, but ocular preparations can cause local reactions.

Common Side Effects: - Transient eye irritation or burning sensation. - Blurred vision shortly after instillation. - Mild foreign‑body feeling in the eye. - Increased tearing or watery discharge. - Mild headache.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) affecting the eye. - Ocular edema or swelling. - Corneal ulceration or epithelial defect. - Sudden loss of vision. - Persistent severe pain in the eye.

Before using Lecrolyn, consider the following precautions.

- Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: unknown safety; weigh potential risks against benefits. - Contact lens wearers: remove lenses before instilling drops and wait several minutes before reinserting. - Concurrent ocular infection: avoid use until infection has resolved. - Store at room temperature below 25°C: keep in the original container, protect from light and moisture.

Lecrolyn may interact with other ophthalmic agents; monitor use accordingly.

Major Interactions (Avoid): - Co‑administration with ocular anesthetic drops may increase irritation.

Moderate Interactions (Monitor Closely): - Use with other topical ocular drugs may require spacing of administration times. - Use with preservative‑containing eye drops can add to local irritation. - Use with contact lens solutions may cause lens discoloration. - Use with systemic corticosteroids should be monitored for overlapping immunomodulatory effects.